The pathological diagnosis before mediation indicated that the patient suffered poorly differentiated squamous cell carcinoma of the cervix. Subsequently, the patient underwent chemotherapy and radiotherapy, with CHA for injection taken as well during the treatment. After 8 months of combined treatment, chemotherapy was discontinued, and the patient continued using CHA alone until January 2022. During the medication, multiple follow-up examinations showed that the patient has stable and improving conditions, with no signs of recurrence or metastasis. The patient’s blood biochemical indicators remained normal, and the patient maintained a good quality of life.